Program Information


A Satellite Symposium during the ATS 2022 International Conference

Continuing Education Dinner Activity


Dinner Service
6:30 PM – 7:00 PM PT
Panel Discussions + Experienced Patient with NCFBE
7:00 PM – 8:30 PM PT



InterContinental San Francisco
Grand Ballroom
888 Howard St
San Francisco, CA 94103


Join us for this in-person CME event, where Drs. Addrizzo-Harris, O’Donnell, and Daley share clinical pearls for the diagnosis and treatment of non-cystic fibrosis bronchiectasis (NCFBE) and a novel emerging treatment targeting the neutrophilic inflammation present in NCFBE.

Joining the panel will be an experienced patient with NCFBE sharing teaching moments about the personal impact of this disease and goals of care.




Doreen J. Addrizzo-Harris, MD (Chair)
Professor, Medicine
Associate Director, Clinical and Academic Affairs
Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY


Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO


Anne E. O’Donnell, MD
Professor, Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Georgetown University Medical Center
Washington, DC


6:30 PM – 7:00 PM
 
7:00 PM – 7:10 PM
 

Doreen J. Addrizzo-Harris, MD
7:10 PM – 7:30 PM
 

Doreen J. Addrizzo-Harris, MD and Panel including Experienced Patient Dana
7:30 PM – 7:55 PM
 

Anne E. O'Donnell, MD and Panel
7:55 PM – 8:20 PM
 

Charles L. Daley, MD and Panel
8:20 PM – 8:30 PM
 

All Faculty


This activity is intended for pulmonary, infectious diseases, radiology, and primary care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).



Upon completion of this activity, participants should be better able to:

  • Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
  • Employ current management strategies for the treatment of patients with NCFBE
  • Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology of NCFBE
  • Assess the potential impact of emerging therapies targeting NSPs on the treatment of NCFBE

Joint Accreditation Statement
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation

Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.



Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at contact@rmei.com.



This activity is provided by RMEI Medical Education, LLC.



This activity is supported by an educational grant from Insmed.



There is no fee for this educational activity.


A MECC-Organized Symposium at the ATS 2022 International Conference

An evening symposia educational program provided by RMEI Medical Education, LLC and supported by an educational grant from Insmed open to all ATS 2022 International Conference attendees.



Facebook  Twitter  LinkedIn

Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.